Lawton v. Takeda Pharmaceutical Company, et al
| UNITED STATES, ex rel. PETER P. LAWTON |
| PETER P. LAWTON, ex rel. UNITED STATES |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a Takeda Pharmaceutica North America, Inc., TAKEDA PHARMACEUTICALS INTERNATIONAL INC., TAKEDA DEVELOPMENT CENTER AMERICAS, INC., f/k/a Takeda Global Research & Development Center Inc. and ELI LILLY AND COMPANY |
| 16-1382 |
| April 14, 2016 |
| U.S. Court of Appeals, First Circuit |
| Other Statutory Actions |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Lawton v. Takeda Pharmaceutical Co.
|
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
107083641
OPINION issued by Sandra L. Lynch, Appellate Judge; Norman H. Stahl, Appellate Judge and David J. Barron, Appellate Judge. Published. [16-1382]
|
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
